Notification of Prohibited Activity Relating to COVID-19.
The U.S. Food and Drug Administration (FDA) considers the sale and marketing of products that claim to prevent, treat, mitigate, diagnose or cure coronavirus disease 2019 (COVID-19) to be a threat to public health. The FDA and Federal Trade Commission (FTC) are actively monitoring for what it views as fraudulent COVID-19 prevention and treatment claims.
As a result, we are taking affirmative steps to prohibit the marketing and sale of products that claim to prevent or treat COVID-19.
While we are monitoring merchants at this time for such activity, if you are engaged in these practices we encourage you to remove such items and promotions from your sites and shelves immediately.
For additional information from government authorities, click the links below:
More from News
3-in-1 Reader | Terminal | Keypad | PINPad Pro | Flex | POS+ | |
---|---|---|---|---|---|---|
Payment types | ||||||
EMV chip card payments (dip) | ||||||
Contactless payments (tap) | ||||||
Magstripe payments (swipe) | ||||||
PIN debit + EBT | ||||||
Device features | ||||||
Built-in barcode scanner | ||||||
Built-in receipt printer | ||||||
Customer-facing second screen | ||||||
External pinpad | ||||||
Wireless use | ||||||
Network | ||||||
Ethernet connectivity | With dock | |||||
Wifi connectivity | ||||||
4G connectivity | ||||||
Pricing | ||||||
Free Placement |